SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-031354
Filing Date
2018-12-24
Accepted
2018-12-21 19:10:16
Documents
3
Period of Report
2018-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-8k_20181220.htm 8-K 47360
2 EX-10.1 apvo-ex101_7.htm EX-10.1 516630
3 EX-10.2 apvo-ex102_6.htm EX-10.2 153321
  Complete submission text file 0001564590-18-031354.txt   718491
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 181250940
SIC: 2834 Pharmaceutical Preparations